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Strains of Clostridium perfringens produce a two-domain
enterotoxin (CpE) that afﬂicts humans and domesticated animals, causing prevalent gastrointestinal illnesses. CpE’s C-terminal domain (cCpE) binds cell surface receptors, followed by a
restructuring of its N-terminal domain to form a membranepenetrating β-barrel pore, which is toxic to epithelial cells of
the gut. The claudin family of membrane proteins are known
receptors for CpE and also control the architecture and function of cell-cell contacts (tight junctions) that create barriers to
intercellular molecular transport. CpE binding and assembly
disables claudin barrier function and induces cytotoxicity via
β-pore formation, disrupting gut homeostasis; however, a
structural basis of this process and strategies to inhibit the
claudin–CpE interactions that trigger it are both lacking. Here,
we used a synthetic antigen-binding fragment (sFab) library to
discover two sFabs that bind claudin-4 and cCpE complexes.
We established these sFabs’ mode of molecular recognition and
binding properties and determined structures of each sFab
bound to claudin-4–cCpE complexes using cryo-EM. The
structures reveal that the sFabs bind a shared epitope, but
conform distinctly, which explains their unique binding equilibria. Mutagenesis of antigen/sFab interfaces observed therein
result in binding changes, validating the structures, and
uncovering the sFab’s targeting mechanism. From these insights, we generated a model for CpE’s claudin-bound β-pore
that predicted sFabs would not prevent cytotoxicity, which we
then veriﬁed in vivo. Taken together, this work demonstrates
the development and mechanism of claudin/cCpE-binding
sFabs that provide a framework and strategy for obstructing
claudin/CpE assembly to treat CpE-linked gastrointestinal
diseases.

Tight junctions are molecular gatekeepers that regulate
transport of small molecules through the paracellular spaces
between adjoining cells in endothelia and epithelia. To
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accomplish this function, tight junctions possess integral
membrane proteins that self-assemble to simultaneously
span both intracellular and paracellular spaces (1, 2). Of
the numerous membrane proteins at tight junctions, the
27-member family of claudins comprise the major structural
and functional backbone of tight junctions, making them
attractive targets to modulate tight junction barriers therapeutically (3). Evolution has successfully accomplished this
feat. Type F strains of the pathogenic Gram-positive bacterium
Clostridium perfringens produce an enterotoxin (CpE) that
binds claudins to dissociate tight junctions during cytotoxicity
in the gut (4–6). In domesticated animals, CpE causes necrotic
enteritis, colitis, and diarrhea (7, 8). In humans, CpE causes
enterotoxemia, which is the third most prevalent foodborne
illness in the United States causing an estimated $400 million
annual economic burden and is the source of a further 4+
million food poisoning cases worldwide—some resulting in
death (8–12). Unlike other human diseases caused by
C. perfringens toxins, CpE-associated ailments are not directly
preventable nor treatable, and no vaccine exists against this
food poisoning type (13). Because spore-formed C. perfringens
is heat-resistant, cooking does little to reduce its pathogenicity,
as digested spores can produce CpE (14). Therefore, submolecular details into CpEs mechanisms of claudin binding
and dissociating tight junction barriers are essential to elucidate CpE cytotoxicity and to develop therapeutic strategies for
CpE-based diseases.
The C-terminal domain of CpE (cCpE) selectively targets
claudins in the gut by recognizing a motif unique to these
receptors, then binds them with low nanomolar afﬁnities (15,
16). This claudin-bound CpE, that is, “small complex”, then
oligomerizes and its N-terminal domain structurally rearranges to form a membrane-penetrating and cytotoxic β-barrel
pore (17, 18). The process of β-pore formation disables
claudin–claudin interactions vital to tight junction assembly
and ultimately dissociates tight junctions causing paracellular
leakage prior to CpE-induced cell death. Crystal structures of
cCpE bound to receptor claudins have shed light on their
interprotein interactions and have helped to inform structureguided design of modiﬁed cCpEs used to detect or destroy
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cancer cells or to modulate the blood-brain barrier for drug
delivery (16, 19–26). Yet, a complete structural and mechanistic understanding of CpE dissociation of tight junctions and
the process of cytotoxic β-pore formation remains elusive.
We intended to elucidate how CpE binds claudins and
dissociates tight junctions by determining X-ray crystal
structures of enterotoxins CpE or cCpE in complex with
claudins but found crystallization to be a bottleneck. For most
claudins, crystals did not form at all, while for those that
formed crystals, it required screening and optimizing hundreds
over 1 year to determine structures resolved to 3 to 4 Å (16,
24). Using a phage display, library-encoding synthetic antigenbinding fragments (sFabs), we sought to discover molecules
that target and bind complexes between enterotoxins and
human claudin-4 (claudin-4). Our goal was to use sFabs to
chaperone crystallization, improve initial diffraction, and increase structural throughput of this and other claudin–
enterotoxin complexes (27, 28). Through this approach, we
surmised additional sFabs could discover that obstruct complex formation altogether and be useful in therapeutic development. During this process, three sFabs were discovered,
which we termed CpE Obstructing Proteins (COPs). Preliminary characterization of COPs revealed that COP-2 and
COP-3 had properties amenable for structure determination of
the claudin-4–cCpE complex. Ultimately, however, we determined a structure of this complex using a traditional crystallography workﬂow (16). But because sFabs have recently been
shown effective for determining structures of small membrane
proteins and complexes by cryo-EM, we used COP-2, COP-3,
and cryo-EM to progress a novel workﬂow for higher
throughput elucidation of claudin/enterotoxin structures (29–
31).
Here, we qualitatively and quantitatively characterize COP2 and COP-3 binding to claudin-4, cCpE, and CpE individually, and to claudin-4–enterotoxin complexes using biochemical and biophysical techniques. We also use cryo-EM at
200 kV to determine 4 to 7 Å structures of each 50 kDa COP
bound to 35 kDa claudin-4–cCpE complexes in 1 month
and employ these structures to create models of the cytotoxic
CpE β-pore. Our ﬁndings reveal the structural basis and COPspeciﬁc mechanisms of COP targeting of claudin-4–cCpE
complexes. This research independently validates claudin-4/
cCpE structures determined by X-ray crystallography and
provides a structural framework for preventing CpE-mediated
cytotoxicity by obstructing toxin/receptor binding. Moreover,
it advances development of technologies and establishes a
general approach for determining structures of other claudin–
enterotoxin complexes at moderate resolutions using accessible cryo-EM instrumentation that can readily be expanded to
higher resolutions with 300 kV microscopes. Further, it demonstrates the antigenicity of CpE and cCpE enterotoxins and
their claudin-bound complexes, which through intensiﬁed
sFab development could generate novel sFabs useful for
modulating tight junction barriers or as therapeutics for preventing or treating CpE-based illnesses in humans and
domesticated animals.
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Results
Development of COPs
Claudin-4 solubilized in n-dodecyl-β-D-maltopyranoside
(DDM) and bound to cCpE was used as input for phage
display selection using a large and diverse library of sFabs
based on a humanized Fab scaffold. The sFab library has
varied sequences that are biased for serine and tyrosine in the
complementarity-determining regions (CDRs) of their light
(L) and heavy (H) chains within variable domains (32, 33).
After several rounds of selection to increase stringency, two
sFabs, termed COP-2 and COP-3, were further developed and
validated by ELISA to bind to claudin-4/cCpE. Both COPs
were sequenced and isolated to characterize their binding
further. Sequence alignments of COP-2 and COP-3 reveal
that COP-2 and COP-3 share 98.2 and 93.3% sequence
identity in their L and H chains, respectively; and that COP
sequences diverge the greatest in CDR-L3, CDR-H1, and
CDR-H3 (Supporting Information (SI) Fig. S1). These residue
divergences may direct COP-speciﬁc recognition of claudin4–cCpE complexes.
Biochemical characterization of COPs
To obtain more detailed insights into COP recognition, we
determined which molecule COPs bind and if they use unique
or common epitopes. After expressing and purifying claudin-4,
cCpE, CpE, and COPs, increases in molecular masses as
assessed by decreases in peak retention times with sizeexclusion chromatography (SEC) was used to qualitatively
characterize COP-2 and COP-3 binding modes. After incubating COP-2 and COP-3 with claudin-4 and cCpE alone, we
found that COPs did not bind claudin-4 but did form larger
complexes with cCpE (Fig. 1, A and B). Incubating claudin-4,
cCpE, and COPs together showed that cCpE binds claudin-4
and that both COPs bound claudin-4–cCpE complexes
(Fig. 1C). No mass increases were observed for COPs incubated with CpE (Fig. 1D). Lastly, incubating claudin-4, CpE,
and COPs together showed that while CpE binds claudin-4
and forms a “small complex”, the COPs do not bind “small
complexes” (Fig. 1E). To verify complex formation, peaks from
SEC were pooled and subjected to SDS-PAGE, which showed
the presence of individual proteins from associated complexes
(Fig. 1F). To determine if COPs share a binding epitope, we
incubated COP-2 and COP-3 together with cCpE. If COPs
bound distinct epitopes, a molecular mass shift greater than
the individual cCpE–COP complex would result. SEC revealed
no additive mass shift with both COPs present (Fig. 1B). These
biochemical results suggest the speciﬁc molecular recognition
of COPs and that COPs share binding epitopes.
Biophysical characterization of COPs
After qualitatively establishing COP binding, we quantitated
the afﬁnities and kinetics of COP interactions with claudin-4
and enterotoxins. We determined the second-order association rate constant (kon), ﬁrst-order dissociation rate constant
(koff), and equilibrium dissociation constant (KD) of these
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Figure 1. Biochemical characterization of COP molecular recognition. Human claudin-4 (hCLDN-4) in DDM, cCpE, CpE, and COP-2 or COP-3 were
incubated together and then injected onto a SEC column equilibrated in DDM and monitoring using 280 nm absorbance. The SEC traces depict the
following: COP-2 (blue) and/or COP-3 (red) binding to (A) claudin-4 alone (green), (B) cCpE alone (orange), (C) claudin-4–cCpE complexes (green), (D) CpE
alone (brown), and (E) claudin-4–CpE complexes (brown green). SEC elution times of MW standards are shown near X axes. (F), SEC peak fractions from (A-E)
were pooled and subjected to SDS-PAGE. cCpE, CpE’s C-terminal domain; COP, CpE obstructing protein; DDM, n-dodecyl-β-D-maltopyranoside; SEC, sizeexclusion chromatography.

interactions using bio-layer interferometry (BLI) (Table 1; SI
Fig. S2). BLI measurements were made using preformed
claudin-4–enterotoxin complexes or cCpE alone in DDM,
replicating the conditions of the phage display selections. For
COP-2 and COP-3 binding to claudin-4–cCpE complexes, we
measured KDs of 52.3 and 98.4 nM, respectively. Comparing
the binding rates revealed that COP-3 had 1.9- and 3.5-fold
faster kon and koff rates than COP-2. The KDs of COP-2 and
COP-3 to cCpE were 67.6 and 137.6 nM, respectively. Like
COP-3 binding to claudin-4–cCpE complexes, the kon and koff
rates were 1.4- and 2.1-fold faster than COP-2. Finally, we
measured KDs of 7.8 and 9.1 μM for COP-2 and COP-3
binding to claudin-4/CpE “small complexes”, respectively.
The KD values represent 149.1- and 92.0-fold decreases in
COP-2 and COP-3 afﬁnity for CpE compared to cCpE. Kinetic
differences in kon and koff of COP binding to cCpE are visible
in the BLI sensorgrams (SI Fig. S2). These results agree with

biochemical assessment and reveal biophysical parameters
unique to each COP that may inﬂuence recognition and
binding to claudin-4–cCpE complexes.

Cryo-EM structures of claudin-4–cCpE–COP complexes
Having conﬁrmed that COP-2 binds claudin-4–cCpE
complexes using SEC (Fig. 2A) and BLI (Fig. 2B), we next
delineated the structural basis and molecular mechanism of
COP-2 targeting by determining its structure by cryo-EM.
Cryo-EM screening of claudin-4–cCpE–COP-2 complexes
that were SEC puriﬁed, pooled, and concentrated to 8.0 mg/ml
in various detergents showed that those solubilized in 2,2didecylpropane-1,3-bis-β-D-maltopyranoside (LMNG) were
amenable to structure determination. This was conﬁrmed by
2D classiﬁcations and ab initio 3D reconstructions, which
revealed a stacked and linear arrangement of the three

Table 1
Afﬁnities and kinetics of COP binding to claudin-4/cCpE and enterotoxins
COP
COP-2
COP-3

Complex/Protein
claudin-4/cCpE
cCpE
claudin-4/CpE
claudin-4/cCpE
cCpE
claudin-4/CpE

kon (1/Ms)
1.5x104
7.2x103
1.5x102
2.9x104
1.0x104
1.2x103

±
±
±
±
±
±

0.1x104
0.6x103
0.6x102
0.7x104
0.1x104
0.2x103

koff (1/s)
7.8x10−4
4.8x10−4
1.2x10−3
2.7x10−3
1.0x10−3
10.8x10−2

±
±
±
±
±
±

0.6x10−4
0.4x10−4
0.6x10−3
0.5x10−3
0.1x10−3
0.7x10−2

KD (nM)
52.3
67.6
7800
98.4
137.6
9050

±
±
±
±
±
±

3.0
11.7
750
11.0
6.2
1300
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Figure 2. Structure and function of COP-2 binding to claudin-4–cCpE complexes. A, SEC puriﬁcation of human claudin-4 (hCLDN-4)–cCpE–COP-2
complexes in LMNG. SEC elution times of MW standards are shown by X axis. B, binding of COP-2 to claudin-4/cCpE using BLI. C, cryo-EM structure of COP-2
(blue) bound to cCpE (copper) and hCLDN-4 (teal). The cryo-EM map (gray mesh) is contoured to 4.0 σ. cCpE, CpE’s C-terminal domain; COP, CpE obstructing
protein; SEC, size-exclusion chromatography; BLI, bio-layer interferometry.

proteins, a canonical two-lobed sFab, and ﬂexibility in COP-2’s
constant domain (SI Fig. S3). Due to this ﬂexibility, we used a
data processing strategy that masked claudin-4, cCpE, and the
variable domains of COP-2 to resolve and focus understanding
on the interactions directing COP-2 recognition. Using this
strategy, a cryo-EM map that was resolved to 6.9 Å was
generated (SI Table S1). The map resolution was sufﬁcient to
reveal the claudin-4–cCpE–COP-2 complex, secondary
structural elements including claudin-4’s four transmembrane
helices (TM), and some bulky side chains (SI Fig. S4A). This
cryo-EM map was used to build, reﬁne, and determine a
structure for the claudin-4–cCpE–COP-2 complex. SI
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Table S1 shows data processing, reﬁnement, and model-tomap ﬁt statistics, with further details given in Experimental
procedures.
The cryo-EM map resolution was insufﬁcient to place side
chains conﬁdently, so we cannot verify interactions between
claudin-4 and cCpE that deﬁne the “cCpE-binding motif” (16).
Overall, however, the claudin-4/cCpE portion of this complex
from cryo-EM superimposed well onto the crystal structure (SI
Fig. S5A). We measured RMSDs in C⍺ positions of 2.0 and
1.4 Å between the cores of claudin-4 and cCpE and 1.7 Å in
overall secondary structures between the cryo-EM and crystal
structures of the claudin-4–cCpE complex, indicating no

Cryo-EM structures of claudin–enterotoxin complexes by Fabs
major conformational changes occur upon COP-2 binding.
Generally, the claudin-4 extracellular segments (ECSs) are in
similar conformations and thus may interact with cCpE
similarly in the cryo-EM and crystal structures (SI Fig. S5A).
Density corresponding to a loop within ECS2 that contains the
NPLVA153 motif shows that the motif accesses a groove on the
surface of cCpE. This interaction is known to impart highafﬁnity cCpE binding to claudins, and COP-2 appears to not
signiﬁcantly alter its structure (16).
The cryo-EM structure of the claudin-4–cCpE–COP-2
complex reveals the basis of COP-2 binding. The canonical
binding of cCpE to claudin-4 exposes cCpE’s top half to COP2 binding by providing an antigenic surface (Fig. 2C). COP-2
binding to cCpE alters the conformations of cCpE’s N-terminus, β-strands β5 and β6, and the loop connecting them, when
compared to the crystal structure (SI Fig. S5A). COP-2’s L
chain sits atop a depression on the exterior of cCpE formed
between the N-terminus and strands β5 and β6 (Fig. 2C).
Chain L’s CDR-L1, CDR-L2, and CDR-L3 conform to the
surface of cCpE and potential side chains involved in these
interactions can be visualized although not placed conﬁdently
(Fig. 4, A and B). COP-2’s chain H accesses the same surface
depression as chain L but also ﬂanks the opposite side of
strands β5 and β6—CDR-H3 shares an epitope with chain L
while CDR-H1 and CDR-H2 reside on the other (Fig. 2C and
Fig. 4C). CDR-H3 splays outward to deeply penetrate its surface groove, conforming to the cCpE surface (Fig. 4D). Based
on the interactions projected by the structure, we hypothesized
that residues comprising Lys197 to Leu202 and Asn267 to
Gln276 in cCpE could inﬂuence COP-2 binding.
After verifying that COP-3 binds claudin-4–cCpE complexes using SEC (Fig. 3A) and BLI (Fig. 3B), we next determined a structure for COP-3 in complex with claudin-4/cCpE
by cryo-EM to contrast its molecular mechanism of targeting
with COP-2. Claudin-4–cCpE–COP-3 complexes in various
membrane mimetics were SEC puriﬁed, pooled, and concentrated to 6.0 mg/ml for cryo-EM. Those complexes solubilized
in amphipol were superior to LMNG and DDM for cryo-EM
based on 2D class averages. The 2D and 3D classiﬁcations of
the COP-3 complex showed a single complex with each protein stacked in a linear arrangement and had features corresponding to secondary structural elements and both lobes of
COP-3 (SI Fig. S6). The 3D reconstructions showed that the
constant domains of COP-3 are less dynamic than those of
COP-2, but also that claudin-4’s TM region was less resolved
in amphipol. We used a data processing strategy that masked
COP-3 to best resolve the interactions directing its recognition
of claudin-4/cCpE, which generated map (focused) that was
resolved to 3.8 Å and showed structural features including
density for bulky side chains (SI Table S1). However, this
focused map lacked deﬁnition for cCpE and claudin-4, and
model-to-map ﬁt proved difﬁcult. Therefore, data were processed with no mask, which produced a map (whole) that was
resolved to 5.0 Å. The whole map resolved the claudin-4–
cCpE–COP-3 complex, including secondary structural elements like claudin-4’s TMs, ⍺-helices and β-strands in cCpE,
and the conformations of COP-3 CDRs (SI Fig. S4B). Initial

model building and reﬁnement employed both maps, but the
ﬁnal model was reﬁned against the whole map, resulting in the
cryo-EM structure for the claudin-4–cCpE–COP-3 complex.
SI Table S1 shows data processing, reﬁnement, and model-tomap ﬁt statistics, with further details given in Experimental
procedures.
The cryo-EM structure of the claudin-4–cCpE–COP-3
complex reveals COP-3’s mode of binding. Compared to the
claudin-4/cCpE crystal structure, the equivalent portion from
the COP-3 cryo-EM structure superimposes well and indicates
that COP-3 does not induce large conformational changes or
affect normal claudin-4–cCpE interactions (SI Fig. S5B). We
measured RMSDs in C⍺ positions of 2.2 and 1.2 Å between the
cores of claudin-4 and cCpE and 2.1 Å between overall secondary structures in the claudin-4–cCpE complex when
comparing cryo-EM and X-ray structures. Like COP-2, COP-3
accesses cCpE’s surface opposite to where claudin-4 binds due
their canonical interactions (Fig. 3C). COP-3 binding to cCpE
alters cCpE’s N-terminus, β5 and β6, and the loop connecting
them, when compared to the crystal structure (SI Fig. S5B).
The L chain of COP-3 binds between cCpE’s N-terminus and
β5 and β6 using CDR-L1 and CDR-L3 (Fig. 4E). The CDR-L3
loop conforms to the surface of this region, potentially using
aromatic side chains to drive shape complementarity (Fig. 4F).
COP-3’s H chain ﬂanks both sides of β5 and β6 of cCpE with
CDR-H3 sharing an epitope with chain L, while CDR-H1 and
CDR-H2 occupy the other side (Fig. 3C and Fig. 4G). COP-3’s
CDR-H3 conforms to and deeply accesses a surface groove
between this region and the N-terminus (Fig. 4H). Based on
the interactions approximated by the structure, we hypothesized that residues comprising Glu198 to Leu202 and Asn269
to Gln276 in cCpE may guide COP-3 binding.
Comparison of COP structures
Because structure resolution was limiting, we used
computational analyses to estimate the COP-speciﬁc residues
used for cCpE recognition. For this, we input the structures
into PDBePISA to determine the properties of the protein
interfaces and then compared areas determined by PDBePISA
to preside over cCpE/COP binding with COP primary sequences (SI Fig. S1) (34). For COP-2, we found that CDR-L3
residues Tyr117 to Ala120, CDR-H1 residue Ser56, and
CDR-H3 residues Tyr125 to Ser137 were unique. For COP-3,
we found that CDR-L3 residues His117 to Tyr121, CDR-H1
residue Tyr56, and CDR-H3 residues Gly125 to Tyr137 were
unique. When compared to a generic sFab, COPs contain
many aromatic side chains and are enriched in serine and
tyrosine in their CDRs. This analysis exposed potential COP
amino acid determinants for recognition and binding to
claudin-4/cCpE.
To contrast COP binding modes and to explain their varied
biophysical binding equilibria, we overlaid the two cryo-EM
structures (Fig. 5). The overlays revealed that 1) the cCpE
poses when bound to claudin-4 are similar but structural
perturbations exist in cCpE due to COP-induced changes; 2)
the claudin-4/cCpE portions exhibit minor structural
J. Biol. Chem. (2022) 298(9) 102357
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Figure 3. Structure and function of COP-3 binding to claudin-4–cCpE complexes. A, SEC puriﬁcation of hCLDN-4–cCpE–COP-3 complexes in amphipol.
SEC MW standard elution times are shown by X axis. B, binding of COP-3 to claudin-4/cCpE using BLI. C, cryo-EM structure of COP-3 (red) bound to cCpE
(copper) and hCLDN-4 (teal). The cryo-EM map (gray mesh) is contoured to 5.0 σ. cCpE, CpE’s C-terminal domain; COP, CpE obstructing protein; SEC, sizeexclusion chromatography; BLI, bio-layer interferometry.

differences between complexes but the claudin-4 TMs are
oriented differently in membrane mimetics; and 3) the COPs
have similar secondary structural elements, but their tertiary
structures and CDRs vary in conformations (Fig. 5A). Focusing
on regions with the largest observable differences, we found
that the L and H chains of each COP conform to cCpE
uniquely. For COP-2 chain L, CDR-L1 and CDR-L3 reside
within the surface groove formed between the N-terminus and
β5-β6 of cCpE while CDR-L2 lies external (Fig. 5B). For COP-3
chain L, the surface groove is depressed due to less N-terminal
length, so while CDR-L1 and CDR-L3 reside in the same
groove, CDR-L1 appears to interact less with cCpE. The
conformation of CDR-H3 may force this CDR-L1 change in

6 J. Biol. Chem. (2022) 298(9) 102357

COP-3. With PDBePISA, we calculated interface surface areas
between the L chain of COPs and cCpE and found that COP2’s area was 36% larger. In both COP’s chain H, the CDR-H1
and CDR-H2 bind on one side of cCpE’s β5-β6 element while
CDR-H3 ﬂanks the other (Fig. 5C). While CDR-H1 and CDRH2 have similar conformations and sequence alignments show
that residue conservation is high, CDR-H3 conformations
appear to vary and residue conservation is low (SI Fig. S1).
Generally, the three CDR conformations overlay well between
both COPs, which is reﬂected by cCpE/H chain interface
surface area differences of only 5%. For both COPs, 80% of
the total cCpE/COP interface area resides in chain H. Overall,
COP-2 appears to use chain L to a higher degree than COP-3,

Cryo-EM structures of claudin–enterotoxin complexes by Fabs

Figure 4. COP recognition of cCpE epitopes. Potential interactions between COP-2 (blue) and cCpE (copper) for the following: (A and B) chain L (light blue)
and (C and D) chain H (dark blue). COP-2 and cCpE are both represented as cartoons (A and C) or COP-2 as a cartoon and cCpE as a surface (B and D).
Potential interactions between COP-3 (red) and cCpE (copper) for the following: (E and F) chain L (red) and (G and H) chain H (maroon). COP-3 and cCpE are
both represented as cartoons (E and G) or COP-3 as a cartoon and cCpE as a surface (F and H). cCpE, CpE’s C-terminal domain; COP, CpE obstructing protein.

J. Biol. Chem. (2022) 298(9) 102357
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Figure 5. Comparison of COP-2– and COP-3–bound claudin-4–cCpE complexes. Structures were overlaid using Chimera (45). A, overlay of COP-2–bound
(blue) and COP-3–bound (maroon) human claudin-4 (hCLDN-4)–cCpE complexes depicted as a surface (left) or cartoon (middle). Model membrane borders
are shown as black lines. Overlays of each protein component were made by removing the other two components for ease of visualization and comparison
(left). B, overlay of COP-2 L chain (blue) bound to cCpE (copper) and COP-3 L chain (red) bound to cCpE (yellow). COPs are represented as cartoons while cCpE
is shown as a semitransparent surface. C, overlay of COP-2 H chain (dark blue) bound to cCpE (copper) and COP-3 H chain (maroon) bound to cCpE (yellow).
Proteins are shown as in (B). cCpE, CpE’s C-terminal domain; COP, CpE obstructing protein.

while both COPs use chain H similarly and dominantly to bind
cCpE. Moreover, the surface structure of cCpE appears to be
altered more by COP-2 than COP-3, indicating that COPspeciﬁc interactions may uniquely mold cCpE’s surface due
to sequence diversity (Fig. 5, B and C). We next determined if
these structural features could explain the differences in
binding equilibria between COP-2 and COP-3 found in vitro.
Quantiﬁcation of COP binding to mutant cCpEs
To test our structures and pinpoint the amino acid determinants of COP binding, we mutated regions of cCpE where
we observed potential interactions with COPs and quantiﬁed
binding with BLI. Preformed claudin-4–cCpEmutant complexes
were used to mimic the sFab selection experiment. First, we
tested all mutants and found that no cCpEmutant affected association with claudin-4, binding with KD’s of 3 nM, similar to
WT cCpE (SI Fig. S2G) (16, 35). We then tested COP binding
to claudin-4/cCpEmutant and compared to claudin-4/cCpEWT
(Table 2). BLI showed that mutant cCpE1, which has a truncated N-terminus, had decreased afﬁnity for COPs. Mutant
cCpE2 increased COP afﬁnities, this mutation lies at the end of
the N-terminus at the start of globular cCpE. Mutant cCpE2
with a Leu202Ala mutation, cCpE2L, showed binding to both
COPs at near cCpEWT levels but indicated a loss of afﬁnity
compared to cCpE2 due to the alanine side chain. Kinetics
reveal that COPs bind claudin-4/cCpE2L at different rates
compared to claudin-4/cCpE2. The mutant cCpE3 in the loop
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connecting β5 to β6 bound with WT afﬁnity to COP-2 but for
COP-3 had 12-fold lower afﬁnity. Both COPs exhibited substantial losses in afﬁnity to mutant cCpE4, which alters residue
lengths in the β5 to β6 loop and β6. COP-2 afﬁnity decreased
270-fold while COP-3 decreased 40-fold. Unlike the other
mutants, cCpE4 affected both kinetic rates, indicating that
cCpE4 perturbs normal COP binding. To put these results in a
structural context, we modeled mutant cCpEs based on our
cryo-EM structures with cCpEWT (SI Fig. S7). The models
provide structural bases for COP binding to mutant cCpEs that
explain our biophysical measurements. Overall, each set of
cCpE mutants, chosen based on their potential for side chain
interactions with COPs, altered COP binding in different ways,
providing in vitro validation of our structures.
Model of cytotoxic claudin-bound CpE pore
To predict COP function in the context of CpE-induced
cytotoxicity, we created models for the process of COP
binding to the claudin-4/CpE “small complex” and for a
claudin-4–bound CpE β-barrel pore complex, using the cryoEM structures as guides. We ﬁrst modeled CpE binding to
claudin-4, then COP recognition of the “small complex”
(Fig. 6A). The model shows in a “small complex” that CpE’s Nterminal domain would sterically shield COP access to their
binding epitopes on cCpE. This ﬁnding explains our results
from biophysical measurements with CpE (Table 1). We next
modeled the claudin-4–bound CpE β-pore complex (Fig. 6B).
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Table 2
Afﬁnities and kinetics of COP binding to claudin-4/cCpEmutant complexes
COP
COP-2

COP-3

Claudin-4/cCpEmutant
CCpEWT
cCpE1
cCpE2
cCpE2L
cCpE3
cCpE4
CCpEWT
cCpE1
cCpE2
cCpE2L
cCpE3
cCpE4

kon (1/Ms)
1.5x104
7.7x103
3.9x104
1.7x104
1.3x104
2.9x102
2.9x104
1.9x104
11.0x104
6.3x104
3.0x104
2.7x103

±
±
±
±
±
±
±
±
±
±
±
±

As there is no structure for the CpE β-pore, we used the cryoEM structure of lysenin, a β-pore toxin with homology to CpE
to model it (36). Lysenin was chosen because attempts to
model the complex using the aerolysin β-pore, another homologous protein, did not place claudin perpendicular to the
membrane plane. This model reveals that when oligomeric
CpE assembles into a β-pore complex that COP access to
cCpE-binding epitopes would be sterically obstructed even if
CpE N-terminal domain rearrangements occur (Fig. 6, B and
C). These structural models explain our in vitro–binding data
and provide a prediction for the effect of COPs on CpEinduced cytotoxicity in vivo.
Effects of COPs on CpE cytotoxicity
Finally, we used a cell-based assay to validate our model of
the claudin-4–bound CpE β-pore and to test if COPs affect
cytotoxicity. Using Spodoptera frugiperda cells that lack
endogenous claudins but form tight junction-like strands
when expressing claudins on their surfaces, we added COPs,
followed immediately by cCpE or CpE, using previously
described methods (16, 24, 37, 38). Control wells had no COPs
or enterotoxins added. We then measured cell viability by
quantifying the amount of cell death instigated by CpE to
determine whether COPs altered cytotoxicity (Fig. 6C). For
cells expressing claudin-4 alone not treated with COPs, we
found that cell viability averaged 73.5%. For these cells, COP
addition decreased average viability by 0.7%, indicating no
COP-induced cytotoxicity. For cells expressing claudin-4
treated with cCpE, which lacks the cytotoxic domain, we
found viability averaged 69.7%. Again, for cCpE-treated cells,
COP addition decreased average viability only 0.8%. Finally, for
cells expressing claudin-4 treated with CpE, we found that cell
viability averaged 31.3%, a decrease of >40% compared to
untreated and cCpE-treated cells, indicating CpE-induced
cytotoxicity. Addition of COPs to CpE-treated cells did not
signiﬁcantly change CpE-induced cell death, decreasing
average viability by 4.3%. These results validate our in silico
model of the claudin-4–bound CpE β-pore and establish the
effect of COPs to CpE-induced cytotoxicity.

Discussion
Here, we demonstrate the development of sFabs called
COPs, COP-2 and COP-3. We show that COPs bind well to

0.1x104
0.5x103
0.5x104
0.1x104
0.1x104
0.1x102
0.7x104
0.2x104
2.2x104
0.2x104
0.3x104
0.2x103

koff (1/s)
7.8x10−4
1.2x10−3
3.3x10−4
1.0x10−3
9.4x10−4
4.2x10−3
2.7x10−3
3.9x10−3
3.0x10−3
5.3x10−3
3.9x10−2
9.4x10−3

±
±
±
±
±
±
±
±
±
±
±
±

0.6x10−4
0.1x10−3
0.4x10−4
0.1x10−3
0.1x10−4
0.1x10−3
0.5x10−3
0.6x10−3
0.1x10−3
0.1x10−3
1.1x10−2
0.1x10−3

KD (nM)
52.3
161.3
8.6
57.2
64.5
14,200
98.4
200.2
24.6
84.4
1225
4010

±
±
±
±
±
±
±
±
±
±
±
±

3.0
0.6
0.1
3.7
4.3
4970
11.0
5.5
4.7
4.8
144
687

cCpE but not to claudin-4 or CpE; COPs bind cCpE better
when bound to claudin-4 than when alone in solution; and that
both COPs bind the same epitope of cCpE opposite to where
claudin-4 binds (Fig. 1). We also show that COP binding to
claudin-4–cCpE complexes yield similar afﬁnities but different
kinetics, with COP-2 associating and dissociating more slowly
than COP-3 (Table 1). As COPs target and bind cCpE on the
opposing surface to its claudin-binding motif, they are therefore capable of binding to any claudin–cCpE complex, making
them general yet strategic tools for enabling structures of
claudin–cCpE complexes.
As proof of this concept, we determine cryo-EM structures for COP-2 and COP-3 bound to claudin-4–cCpE
complexes, which reveal the cCpE-binding epitope and the
potential interaction interfaces for the L and H chains of
COPs (Fig. 2 and Fig. 3). Our structures and computational
analyses show that COP-2 has an 11% larger cCpE/COP
interface area, that COP-2 uses chain L CDR-L1 uniquely,
and that its binding conforms to or molds cCpEs surface to a
greater extent than COP-3, which explains its higher afﬁnity
and slower kinetic rates than COP-3. These analyses also
reveal a common binding property to COPs where chain H
interacts with both sides of a β5-β6 epitope in a mechanism
similar to a caliper brake on a bicycle (Fig. 4, D and H).
Holistically, the cryo-EM structures resemble and thus
provide independent validation of the claudin-4–cCpE
complex crystal structure.
To validate these moderate resolution cryo-EM structures,
we mutate the observed COP-binding epitopes on cCpE and
quantify mutant effects to COP binding. For this, we mutated
side chains in sequential three to ﬁve residue zones. We show
that all mutations affect cCpE/COP binding afﬁnity, kinetics,
or both (Table 2). Some, like mutants cCpE3 and cCpE4,
display COP-speciﬁc differences in their binding and thus
pinpoint cCpE residues that are uniquely recognized by COP-2
or COP-3. The changes to COP binding by cCpE mutants
in vitro validate our cryo-EM structures by attesting to the
accuracy of their modeled cCpE/COP interfaces. We further
show that models of mutant cCpE–COP complexes guided by
our structures elucidate the structural bases of mutant effects
to COP binding (SI Fig. S7). In sum, these results provide the
likely amino acid determinants and biophysical interaction
mechanisms that direct COP-speciﬁc recognition of and
binding to cCpE.
J. Biol. Chem. (2022) 298(9) 102357
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Figure 6. Models for COP binding to claudin-4/cCpE and the claudin-4–bound CpE β-pore. A, CpE (copper) binding to the ECS of hCLDN-4 (teal) forms
the “small complex”. The N-terminus of CpE sterically shields the COP (blue) binding epitope on cCpE, preventing high-afﬁnity interactions. B, model for a
CpE β-pore (gray) based on lysenin with one hCLDN-4 (teal) bound to the cCpE domain of a CpE monomer (black). Rearrangement of the CpE N-terminus
forms the β-pore. Despite rearrangement, CpE assembly and its N-terminus sterically shield COP (blue) engagement with its binding epitope. C, zoom-in on
the sterically shielded region shows CDRs from the L and H chains cannot access cCpE. Scatter plot shows the functional effect of COP addition to CpEinduced cytotoxicity of insect cells expressing hCLDN-4. The graph plots the mean and SD based on ﬁve readings. Proteins are represented as cartoons or as
a translucent surface-encapsulated cartoon in the case of the CpE β-pore (B). cCpE, CpE’s C-terminal domain; COP, CpE obstructing protein; ECS, extracellular
segment.

We further present models for the claudin-4/CpE “small
complex” and claudin-4–bound CpE β-pore complex in order
to understand our structures in a functional context and to
predict COP efﬁcacy for use as CPOs (Fig. 6). One model
shows that when CpE is bound to claudin-4 in a “small complex”, the N-terminus of CpE sterically shields COP-binding
epitopes (Fig. 6A). This model is veriﬁed by our ﬁnding that
COP-2 and COP-3 bound CpE with 100-fold lower afﬁnity
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than cCpE (Table 1). Using the homologous β-pore–forming
toxin lysenin as a benchmark, we also show how CpE may
oligomerize to form its membrane-spanning β-pore upon
binding to claudin-4 (Fig. 6B). This model shows that COPs
are sterically occluded from accessing their epitopes on cCpE
due to CpE oligomeric assembly and N-terminal β-pore
engagement (Fig. 6C). Based on this model, we hypothesized
that COPs would be ineffective at preventing CpE-induced
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cytotoxicity. We test this hypothesis using a cell-based cytotoxicity assay and show that COPs do not prevent nor alter
cytotoxicity induced by CpE (Fig. 6C). This ﬁnding veriﬁes our
hypothesis and provides evidence that our model of the CpE βpore is potentially useful to predict the functional effects of
structural changes to CpE upon binding claudin-4 and forming
a cytotoxic β-pore.
Based on these data and results, we propose a framework for
using COP-like molecules to target and obstruct CpE cytotoxicity (Fig. 7). We envision three strategies based on the
proposed sequence of events that lead to CpE β-pore formation (17, 18). These include developing COPs that 1) obstruct
formation of claudin-4/CpE “small complexes”, 2) stabilize the
native fold of CpE’s N-terminus to prevent its structural
rearrangement that induces cytotoxicity via β-pore formation,
and 3) obstruct CpE oligomerization prior to β-pore assembly.
Using our models for the “small” and claudin-4–bound CpE
β-pore complexes, we identify ﬁve areas where binding by
COP-like sFabs could obstruct CpE binding, conformational
changes, or oligomerization, potentially preventing CpE-based
cytotoxicity. Area A is a surface pocket between β8 and β9 on
the cCpE domain of CpE (Fig. 7A); and area B comprises the
two ECS of claudins and includes the NPLVA153 motif that
imparts high-afﬁnity CpE binding (Fig. 7B) (16). Development
of COPs that bind area A or B would inhibit formation of the
“small complex” by obstructing areas known to facilitate
claudin-4–cCpE interactions, thus preventing CpE prepore
and β-pore complex formation (Strategy 1). Area C is a region
of CpE’s N-terminus that may structurally rearrange upon CpE
assembly forming a long, antiparallel β-barrel to create the
membrane-penetrating β-pore (Fig. 6B and Fig. 7C). Discovery
of COPs that bind area C may stabilize CpE’s N-terminus to
disable its β-pore–forming conformational transition (Strategy
2)—they may also obstruct CpE oligomerization (Strategy 3).
Finally, area D includes strand β1 and helix ⍺1 of cCpE; while

area E comprises two loops that connect β2 to β3 and β8 to β9
(Fig. 7C). Based on our models, areas D and E represent
additional areas where COP binding could sterically obstruct
CpE oligomerization. In summary, our models reveal that 1)
for COP binding to areas A or B to be effective at obstructing
cytotoxicity, they will need to be present before or during CpE
production to prevent “small complex” formation and 2) COP
binding to areas C, D, or E would not prevent “small complex”
formation and thus could be effective postproduction of CpE
but would need to be present prior to CpE’s oligomeric assembly of its β-pore. This proposed structure-based framework can inform therapeutic strategies that utilize yet to be
developed COPs to target CpE, claudin-4, or claudin-4–CpE
complexes. COPs that bind the above-mentioned areas could
obstruct CpE β-pore formation and thus prevent CpE-linked
cytotoxicity. Such molecules could be potent therapeutics,
capable of treating CpE-linked gastrointestinal illnesses, afﬂict
millions of humans and domesticated animals globally,
resulting in large economic burdens and losses in quality of
life.

Conclusions
In this study, we progress a novel workﬂow for structural
determination of claudin–enterotoxin complexes using 200 kV
cryo-EM instrumentation that yields 4 to 7 Å resolutions. Our
approach is amenable to other cCpE-binding claudins in a
variety of membrane mimetics and is enabled by COPs, which
add mass, rigidity, and act as ﬁducial marks (SI Fig. S8). COPs
are versatile, capable of being used for cryo-EM and/or as
crystallization chaperones for X-ray diffraction. Although the
cryo-EM workﬂow described here produces modest resolution
structures, it must be considered that these complexes are
small by cryo-EM standards at 35 kDa. We estimate that their
already detailed maps could be improved to 3 to 4 Å using

Figure 7. COP targeting strategies to obstruct CpE cytotoxicity. A, COPs (blue) that target the cCpE domain of CpE (copper) by binding to Area A, a
solvent-accessible pocket between β8 and β9 of cCpE that is known to interact with claudin-4’s NPLVA153 motif, which is critical for “small complex”
formation. B, COPs (blue) that target hCLDN-4 (teal) by binding to Area B, the two ECS of claudins, which coordinate to interact with cCpE and form a “small
complex”. C, COPs (red, black, green) that target CpE (copper) by binding to Areas C, D, and E. Area C comprises Pro65-Pro124 of CpE’s N-terminus, which
contains a purported Thr92-Gly105 ⍺-helix used for β-pore formation. Area D comprises Ala203-Asn218 of cCpE, which contains its β1 strand and ⍺1 helix.
Area E comprises Ser229-Asn236 and Ser304-Pro311 of cCpE, which contain two loops that connect strands β2 to β3 and β8 to β9. These three areas may be
used for CpE assembly and thus COP binding could obstruct this assembly, trapping “small complexes” that are inert and not cytotoxic. cCpE, CpE’s
C-terminal domain; COP, CpE obstructing protein; ECS, extracellular segment.
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300 kV microscopes (SI Fig. S4). Achieving these resolutions
would equal current results from crystallography of claudin–
cCpE complexes and have the added advantage of enabling
structure determination of complexes recalcitrant to crystallization or complexes that crystallize but diffract X-rays
weakly. Thus, COPs are multiuse tools to expand structural
knowledge of other claudins that bind enterotoxins. For this
and their potential obstructing capacities, COPs and COP-like
sFabs may provide new insights useful for developing treatments for CpE-based diseases or to aid design of novel cCpEand CpE-based therapeutics that modulate tight junction
barriers.

Experimental procedures
Claudin-4 and enterotoxin expression and puriﬁcation
Methods followed those described previously (16, 24).
Brieﬂy, claudin-4, cCpE, and CpE with C-terminal decahistidine tags preceded by thrombin cleavage sites (claudin-4His10, cCpE-His10, and CpE-His10) were cloned into pFastBac1
(ThermoFisher) and expressed in Tn5 (Trichoplusia ni, High
Five, Expression Systems, LLC). Cell pellets resuspended in
lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1 mM PMSF,
and EDTA-free SigmaFast protease tablets (Sigma)) were
sonicated, supplemented with 1 M NaCl, then ultracentrifugation at 100,000×g for 1 h. For enterotoxins, the supernatant
was saved, 15 mM imidazole was added along with NiNTA
resin, and the solution was incubated for 12 h at 4  C. For
claudin-4, the supernatant was removed, and the membrane
pellet was resuspended in lysis buffer and the protein was
solubilized with 1% (w/v) DDM (Anatrace) and 0.04% cholesteryl hemisuccinate (Anatrace) overnight at 4  C. Insoluble
protein was removed by ultracentrifugation at 100,000×g for
30 min, and the supernatant was treated with 15 mM imidazole along with NiNTA resin, and the solution was incubated
for 12 h at 4  C. For claudin-4, the bound protein was captured
and washed with ﬁve column volumes of buffer A (50 mM Tris
pH 7.4, 500 mM NaCl, 25 mM imidazole, and 0.087% DDM)
and buffer B (buffer A containing 300 mM NaCl and 40 mM
imidazole). Buffer T (50 mM Tris pH 8.0, 150 mM NaCl and
0.04% DDM) was used to release and capture proteins from
the resin after treatment with thrombin. For enterotoxins,
puriﬁcation was similar to claudin-4 except DDM was not
added to buffers. These proteins were then used for sFab
panning or biochemical, biophysical, and structural analyses.
For enterotoxins used for binding studies, the proteins were
eluted off of NiNTA using elution buffer (buffer T containing
400 mM imidazole) to keep the His10 tag. Eluted enterotoxinHis10 was dialyzed in SEC buffer (10 mM Hepes pH 7.4,
100 mM NaCl, and 4% glycerol), concentrated to 1 mg/ml,
then ﬂash-frozen in liquid nitrogen and stored at −80  C until
use.
Generation and validation of COPs using phage display
DDM-solubilized claudin-4 was biotinylated using
N-hydroxysuccinimide polyethylene glycol biotin (NHSPEG4-biotin, ThermoFisher) by mixing 5.6 μM claudin-4 with
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16.8 μM NHS-PEG4-biotin, followed by incubation on ice for
2 h. Excess cCpE with the His10 removed was added at a ratio
of 1:1.5 (moles:moles), then free biotin and unbound cCpE was
removed by loading the sample onto a Superdex 200 Increase
10/300 Gl (Cytiva) equilibrated in SEC buffer containing 0.04%
DDM. The sFab panning was performed using the sFab library
E (32, 33). Binding was assayed in selection buffer (25 mM
Hepes pH 7.4, 150 mM NaCl, and 1% bovine serum albumin).
A ﬁrst round of panning was performed manually using
200 nM of biotinylated claudin-4/cCpE in DDM immobilized
onto magnetic beads, and following three washes with Selection buffer, the beads enriched for phage-expressing claudin-4/
cCpE-speciﬁc sFabs were used to infect log-phase Escherichia
coli XL1-Blue cells. Phages were ampliﬁed overnight in 2xYT
media supplemented with 100 μg/ml ampicillin and M13-KO7
helper phage (109 pfu/ml). Selection stringency was then
increased by four additional rounds of panning using
decreasing claudin-4/cCpE concentrations down to 20 nM.
For each round, the ampliﬁed phage pool from each preceding
round was used as the input. For rounds two to ﬁve, panning
was performed semiautomatically using a Kingﬁsher magnetic
beads handler (ThermoFisher). Nonspeciﬁc binding of sFabs to
detergent was reduced by using >0.87% DDM in later rounds.
Bound phage particles were removed by elution from beads
using 1% Fos-choline-12.
The initial validation was performed by single-point phage
ELISA using individual clones from later selection rounds.
ELISAs were performed in 96-well plates (Nunc) coated with
2 μg/ml neutravidin and blocked with selection buffer. E. coli
XL1-Blue colonies–containing phagemids were used to
inoculate 400 μl 2xYT media containing 100 μg/ml ampicillin
and 109 pfu/ml M13-KO7 helper phage. Phages were ampliﬁed overnight in 96-well deep-well blocks at 37  C with
shaking at 280 rpm. Phages were then diluted 1:10 into selection buffer and assayed against claudin-4/cCpE in DDM or
buffer containing only DDM micelles. Biotinylated claudin-4/
cCpE was immobilized at room temperature for 30 min, then
incubated with phage dilutions. Bound phage were detected
with TMB substrate (ThermoFisher) following a 30 min incubation with horseradish peroxidase–conjugated anti-M13
monoclonal antibody (GE Healthcare). Absorbance was
measured at 450 nm after quenching the reaction with 1.0 M
HCl. Wells containing 1% DDM were used to detect
nonspeciﬁc binding.
COP expression and puriﬁcation
Two sFabs termed COP-2 and -3, from phage ELISA, were
selected and sequenced at the University of Chicago
Comprehensive Cancer Center DNA Sequencing facility.
Unique clones for each COP were subcloned in pRH2.2 using
the In-Fusion Cloning kit (Takara Bio). Sequence-veriﬁed
COPs were transformed into E. coli BL21-Gold cells (Agilent) and then used to inoculate overnight cultures. The inoculates were then used to seed 1 l of 2xYT media containing
100 μg/ml ampicillin. Cultures were grown to an A600 of 0.8,
induced for 4 h at 37  C, then cells were harvested using
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centrifugation. Cell pellets were resuspended in COP lysis
buffer (20 mM Hepes pH 7.4, 150 mM NaCl, 0.5 mM MgCl2,
1 mM PMSF, and 1 μg/ml DNase I). Cells were sonicated and
lysates were incubated at 60  C for 30 min to remove proteolyzed fragments. Samples were cooled rapidly on ice then
cleared by centrifugation. Supernatants were ﬁltered by
0.45 μm and loaded onto a 5 ml HiTrap MabSelect SuRe
column (GE Healthcare) equilibrated with COP Wash buffer
(20 mM Hepes pH 7.4 and 500 mM NaCl). The column was
washed with 10 column volumes of COP Wash buffer, and
COPs were eluted with 0.1 M acetic acid. Eluted COPs were
loaded onto a 1 ml Resource S column (GE Healthcare)
equilibrated with COP buffer A (50 mM sodium acetate pH
5.0) and washed with 10 column volumes of this buffer. The
COPs were eluted by linear 0 to 50% gradient with COP buffer
B (COP buffer A containing 2 M NaCl). COP-containing
fractions were pooled and dialyzed overnight at 4  C in SEC
buffer.
Biochemical characterization of COP binding
We used post-NiNTA–puriﬁed untagged claudin-4 and
enterotoxins and postafﬁnity-puriﬁed COPs for these analyses.
For claudin-4/COP and enterotoxin/COP studies, 50 μg enterotoxins was used and excess COPs were added at a 1:1.2 M
ratio, incubated at room temperature for 1 h, concentrated,
0.2 μm ﬁltered, then loaded onto a Superdex 200 column
equilibrated in SEC buffer containing 0.04% DDM. For
claudin-4/enterotoxin/COP studies, 50 μg claudin-4 was used
and excess enterotoxins were added at a 1:1.2 M ratio, then
COPs were added at a 1:1 M ratio to enterotoxins. Complexes
were incubated, concentrated and ﬁltered, and loaded onto a
Superdex200 column equilibrated in SEC buffer and 0.04%
DDM. Complex formation was assessed by observed decreases
in the elution times of the uncomplexed peak fractions. Peak
fractions containing complexes were pooled, unboiled, and
evaluated for the presence of each protein by SDS-PAGE using
4 to 20% agarose gradient gels.
Biophysical characterization of COP binding using BLI
BLI analyses were performed at 25  C at an acquisition rate
of 5 Hz averaged by 20 using an Octet© BLItz System (FortéBio/Sartorius), with assays designed and setup using Blitz
Pro 1.3 Software. A typical experiment consisted of the
following steps: sensor equilibration (30 s), protein loading
(200 s), baseline (60 s), and association and dissociation (300 s
each). For the loading step, 4 μl of proteins were loaded in the
drop holder, while all other steps were performed in transparent 600 μl microtubes using 250 μl sample volumes. All
measurements were performed in SEC buffer containing 0.04%
DDM. For cCpE/COP studies, 5 μM (70 μg/ml) of WT cCpEHis10 was loaded on NiNTA (Dip and Read) sensors then
dipped into a 0 to 1 μM range of four concentrations of COPs
for the association steps. For claudin-4/enterotoxin/COP
studies, 5 μM DDM-solubilized claudin-4 biotinylated with
NHS-PEG4-biotin as before was precomplexed with excess
WT or mutant cCpE or CpE without a His10 at a ratio of 1:2

(moles:moles) for 1 h at room temperature. Claudin-4–
enterotoxin complexes were loaded on Streptavidin-SA (Dip
and Read) sensors and the measurements were performed as
above using 0 to 30 μM range of concentrations depending on
the analyte. For claudin-4/mutant cCpE studies, 5 μM of
biotinylated claudin-4 in DDM was immobilized on SA sensors and measurements were performed as above using a 0 to
0.25 μM concentration range of cCpEs. For all studies, measurements were repeated in at least duplicate, and the time
courses for association and dissociation were ﬁt to one-site–
binding model using the BLItz Pro 1.3 Software. No major
nonspeciﬁc binding of COPs to unloaded NiNTA or streptavidin sensors were detected at concentrations up to 30 μM.
Cryo-EM sample preparation
DDM-solubilized claudin-4 was exchanged into 2,2didecylpropane-1,3-bis-β-D-maltopyranoside (LMNG, Anatrace) or amphipol A8-35 (Anatrace). For exchange into
LMNG, the protein bound to NiNTA resin was sequentially
washed with buffer A, B, and T containing 0.087, 0.087, and
0.04% LMNG, respectively, before releasing the bound protein
from resin via thrombin cleavage. To prepare sample in
amphipol, 1 mg of postthrombin-digested claudin-4 in DDM
was treated with 4 mg of amphipol (1:4 w/w) for 2 h before
removing detergent via addition of 400 mg SM-2 biobeads
(Bio-Rad). Excess cCpE was added to each claudin-4 sample at
a molar ratio of 1:1.5, incubated at room temperature for 1 h,
then excess COPs were added at a 1.5:1 ratio to cCpE. After
1 h at room temperature, each sample was concentrated,
0.2 μm ﬁltered, and then loaded onto a Superdex 200 Increase
10/300 Gl equilibrated in SEC buffer without glycerol but with
0.003% LMNG or no detergent for amphipol samples. Peak
fractions from SEC-containing claudin-4–cCpE–COP complexes were collected and concentrated to 6 to 8 mg/ml for use
in cryo-EM analyses.
Grids for cryo-EM analyses were prepared using a Vitrobot
Mark IV (ThermoFisher) plunge freezing apparatus. Aliquots
(3 μl) of claudin-4–cCpE–COP complexes in LMNG or
amphipol were applied to Quantifoil R1.2/1.3200 mesh grids
that were glow-discharged for 45 s at 15 mA in a Pelco easiGlow (Ted Pella Inc) instrument. Protein solutions were
applied to grids at 4  C and 100% relative humidity and
allowed to adsorb on the grid for 30 s before blotting. Grids
were blotted for 5 to 8 s with a blot force of 1 and plunge
frozen into liquid ethane cooled by liquid nitrogen. Grids were
stored in liquid nitrogen prior to imaging.
Cryo-EM data collection and processing
Cryo-EM data collection was performed on a Talos Arctica
(ThermoFisher) equipped with a Falcon III (ThermoFisher)
direct electron detector at Michigan State University. Grids
were screened for thin ice and good particle distribution, and
data collection was performed using EPU software (ThermoFisher). Movies of claudin-4/cCpE/COP-2 in LMNG were
collected on the Falcon III detector in counting mode at
92000× magniﬁcation with a pixel size of 1.12 Å, a defocus
J. Biol. Chem. (2022) 298(9) 102357
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range of 0.8 to 2.6 μm, and a total dose of 32 electron/Å2
fractionated over 51 total frames. Movies of claudin-4/cCpE/
COP-3 in amphipol were collected at 120000× magniﬁcation
with a pixel size of 0.87 Å, a defocus range of −1 to −2.2 μm,
and a total dose of 40 electron/Å2 fractionated over 42 total
frames.
All micrograph and particle processing was performed in
CryoSPARC (39). Patch-motion correction and patch-CTF
correction were used to correct for beam-induced motion
and calculate CTF parameters from the motion-corrected
micrographs. Blob-based template picking followed by 2D
classiﬁcation was used to generate templates that were subsequently used for template-based particle picking. Particles
identiﬁed from this template-based picking procedure were
subjected to several rounds of 2D classiﬁcation, followed by
ab initio 3D reconstruction, heterogeneous reﬁnement, and
nonuniform reﬁnement. In the case of the COP-3 complex,
local reﬁnement using a soft mask around cCpE and COP-3
was also used to improve resolution at the complex’s
interface.
Cryo-EM model building, reﬁnement, and structure
determination
Using postprocessing maps, we ﬁrst built the structure of
claudin-4/cCpE/COP-2 using the 6.9 Å map and the crystal
structure of claudin-4 in complex with cCpE (PDB ID 7KP4)
(16). 7KP4 was manually docked by placing the four TMs of
claudin-4 into density present in the LMNG micelle using
Coot (40). TM placement was validated using density corresponding to bulky side chains, like Trp18 in TM1 of claudin-4.
Initial placement of the TM region showed that only minor
alterations to claudin-4’s ECS and cCpE would be required to
ﬁt well within the cryo-EM map. For this part of the structure,
the map volume allowed placement of most claudin-4 and
cCpE residues, with the exception of claudin-4’s C-terminus
and cCpE’s N-terminus. We next built COP-2 by ﬁrst using a
high-resolution crystal structure of an sFab (PDB ID 6CBV).
COP-2 was manually docked into the additional cryo-EM
density using Coot, and then divergent residues of COP-2
were manually mutated from the 6CBV template using
sequence alignments as a guide (41). Once the three proteins
were ﬁt manually, each of the four protein chains were rigid
body reﬁned in Coot to place the structure within the cryo-EM
map volume. Model building was done using Coot and once
complete, the structure was further reﬁned using a combination of molecular dynamics (MD) ﬂexible ﬁtting simulations
using Namdinator followed by real-space reﬁnement of the
model into the cryo-EM density map using Phenix phenix.real_space_reﬁne (42, 43). The ﬁnal structural model
required secondary structure and Ramachandran restraints to
optimize the model-to-map ﬁt and overall geometry. SI
Table S1 shows data collection, reﬁnement, and validation
statistics for the claudin-4/cCpE/COP-2 structure.
The structure of claudin-4/cCpE/COP-3 was determined
using both a masked and unmasked strategy, which produced
focused and whole maps that resolved to 3.8 and 5.0 Å,
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respectively. A mask was applied to COP-3 and cCpE of the
complex in the former case, while all three proteins were
included (unmasked) in the latter. The ﬁnal model of the
claudin-4–cCpE–COP-2 complex was manually docked, then
COP-3 was made from COP-2 by mutating divergent residues
using sequence alignments. Each protein chain in the complex
was then individually reﬁned as rigid bodies into the cryo-EM
maps using Coot. While the focused map had added features
for COP-3 and cCpE, because of the mask, it lacked density for
claudin-4 and reﬁnements using the three-protein complex
resulted in poor model-to-map ﬁts. Thus, all three proteins
were built and ﬁt manually within the whole map volume using
Coot and the ﬁnal model was reﬁned using Namdinator and
Phenix phenix.real_space_reﬁne using secondary structure and
Ramachandran restraints (42, 43). The deposited PDB ID
7TDN is a result of reﬁning against the whole cryo-EM map. SI
Table S1 shows data collection, reﬁnement, and validation
statistics for the claudin-4/cCpE/COP-3 structure.
The programs used to visualize and build the structures
included Coot, PyMOL, and Chimera, reﬁned using Phenix,
and Figures were made using PyMOL—using the SBGrid
Consortium Software Suite (40, 44–47).
Mutagenesis of cCpE
The cCpE-His10 was altered using site-directed mutagenesis. Mutants were generated with the following forward and
equivalent reverse primers:
cCpE1
50 -gcgcggatccgccaccgcatcaacggacattatgaaagaaa
tcctcgac-3’;
cCpE2 50 -ccatgtcaacggacattgaaaaagaagccgccgccttagctgctgcaa
cagaacgc-3’;
cCpE2L 50 -ccatgtcaacggacattgaaaaagaagccgccgccgccgctgctg
caacagaacgc-3’;
cCpE3
50 -gttgactttaacatttactccaacgccgccgctgcccttgtcaaa
ctcgaacaatcgctc-3’;
cCpE4
50 -catttactccaacaacttcaataacgctgccaaagccgcacaat
cgctcggagatggtg-3’. Expression and puriﬁcation of all cCpEHis10 mutants were identical to those of WT cCpE-His10.
Amino acid sequence alignments comparing mutant cCpE
to WT are provided to aid interpretation.
cCpE1
cCpE2
cCpE2L
cCpE3
cCpE4

CCpEWT
cCpEΔ192-196
cCpEWT
cCpEAla199-201
CCpEWT
cCpEAla199-202
cCpEWT
cCpEAla267-270
cCpEWT
cCpEAla271-272/274-275

192

STDIEKEILDLAAATERLN210
KEILDLAAATERLN210
192
STDIEKEILDLAAATERLN210
192
STDIEKEAAALAAATERLN210
192
STDIEKEILDLAAATERLN210
192
STDIEKEAAAAAAATERLN210
260
DFNIYSNNFNNLVKLEQ276
260
DFNIYSNAAAALVKLEQ276
260
DFNIYSNNFNNLVKLEQ276
260
DFNIYSNNFNNAAKAAQ276
197

Structural modeling of claudin-bound CpE pore
A model of claudin-4/CpE was made by superposing CpE
(PDB ID 3 AM2) onto cCpE from our cryo-EM structure of
the COP-2 complex, making a claudin-4/CpE/COP model. To
approximate the CpE β-pore, we modeled it after lysenin, a βpore toxin with homology to CpE, using an available cryo-EM
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structure (PDB ID 5GAQ) (36, 48). Using a crystal structure of
the lysenin monomer (PDB ID 3ZXD), we superposed 3ZXD
onto one monomer of the 5GAQ nonamer and then superposed the CpE portion of our claudin-4/CpE/COP model onto
3ZXD (49). We next removed 3ZXD. This process integrated
claudin-4/CpE/COP into lysenin, making the model for the
claudin-4–bound CpE β-pore. These models were used to
predict COP inﬂuence on CpE-induced cytotoxicity.
Cell-based cytotoxicity assay
Recombinant baculoviruses–containing claudin-4-His10
were produced using established methods and the cytotoxicity assay was performed using methods previously
described (16). To 18 wells of a 24-well cell culture plate,
0.5 ml of 1.0 x 106 adherent Sf9 (S. frugiperda, Expression
Systems) cells were added. After 1 h at 27  C, virus–
containing claudin-4-His10 was added at a MOI of 1.0. Cultures were rocked gently and then placed at 27  C for 48 h.
The 18 wells were divided into three, 6-well groups. To
duplicate wells of group one and three, 22 μg (0.9 μM) of
COP-2 was added; to a second pair of wells, 22 μg (0.9 μM) of
COP-3 was added; and to the third pair of wells, no COP was
added. To duplicate wells of group two, 100 μg (4 μM) of
COP-2 was added; to a second pair of wells, 100 μg (4 μM) of
COP-3 was added; and to the third pair of wells, no COP was
added. For group one, nothing more was added; this group
contained only cells expressing claudin-4-His10. For group
two, 25 μg (3.3 μM)–puriﬁed cCpE in SEC buffer was added
to the culture medium. For group three, 12.5 μg (0.7 μM)
CpE in SEC buffer was added to the culture medium. The
COP amounts added correspond to 1.2-fold molar excess of
COP to enterotoxin. After addition of COPs and/or enterotoxins, Sf9 cells were placed at 27  C for 12 h, then CpE
cytotoxicity was quantiﬁed using a cell viability analysis. This
was done by gently removing 250 μl of Sf9 cells from each
well, centrifuging at 200×g for 2 min, removing 200 μl of
media, then adding 50 μl of 0.04% trypan blue. After 5 min,
10 μl of stained cells were transferred to a Countess cell
counting chamber slides and counted automatically using a
Countess 3 automated cell counter (ThermoFisher). Each
well was counted at least two times with one well counted
three times (representing ﬁve readings per sample, 45 for
nine samples). Viability counts consisted of dividing the total
number of live cells (unstained) by the total number of cells.
Average cell viability for enterotoxin-treated cells was
compared to Sf9 cells expressing claudin-4 that were not
treated with either enterotoxins or COPs. Data was plotted as
a mean with SD in GraphPad Prism 9 for macOS.

Data availability
The cryo-EM structure of claudin-4/cCpE/COP-2 has
accession code 7TDM in the Protein Data Bank (PDB), and
cryo-EM maps of this complex have been deposited to the
Electron Microscopy Data Bank under accession code EMD25834. The cryo-EM structure of claudin-4/cCpE/COP-3 has

PDB accession code 7TDN, and cryo-EM maps of this complex have been deposited to the Electron Microscopy Data
Bank under accession code EMD-25835 (whole) and EMD25836 (focused).
Supporting information—This article contains Supporting information (50).
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